Status:
COMPLETED
Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position
Lead Sponsor:
Heidelberg Engineering GmbH
Collaborating Sponsors:
Duke University
Conditions:
Retinal Disease
Healthy Eyes
Eligibility:
All Genders
22+ years
Brief Summary
This is a prospective clinical study conducted at one clinical site in the United States.
Detailed Description
The conducted study is an observational study for an imaging device used in the aid of ophthalmology diagnosis.
Eligibility Criteria
Inclusion
- Adult Normal Eyes Population (AN)
- Inclusion Criteria for AN Population
- Age ≥ 22 years
- Able and willing to undergo the test procedures, sign informed consent, and follow instructions.
- Physically able to be positioned in all required imaging positions (upright at chinrest and supine).
- Able to fixate.
- Best corrected visual acuity ≥ 20/40 in both eyes.
- Exclusion Criteria for AN Population
- Eye with ocular media not sufficiently clear to obtain acceptable study-related imaging.
- Subjects who cannot tolerate the imaging procedures.
- Clinically significant ocular disease in either eye as determined by an Investigator.
- Ocular surgical intervention (except for refractive laser surgery or cataract surgery) in either eye.
- Adult Posterior Segment Abnormality Eye Population (AD)
- Inclusion Criteria for AD Population
- Age ≥ 22 years
- Able and willing to undergo the test procedures, sign informed consent, and follow instructions.
- Physically able to be positioned in all required imaging positions (upright at chinrest and supine).
- Able to fixate.
- Eye with a structural and vascular posterior segment abnormality due to ocular disease and/or trauma.
- Exclusion Criteria for AD Population
- Eye with ocular media not sufficiently clear to obtain acceptable study-related imaging.
- Subjects who cannot tolerate the imaging procedures.
Exclusion
Key Trial Info
Start Date :
December 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 22 2024
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04661124
Start Date
December 10 2020
End Date
April 22 2024
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Eye Center
Durham, North Carolina, United States, 27705